Nebulised recombinant activated factor VII (rFVIIa) does not attenuate the haemorrhagic effects of blast lung injury

INTRODUCTION: Primary blast lung injury causes intrapulmonary haemorrhage. A number of case reports have suggested the efficacy of recombinant activated factor VII (rFVIIa) in the treatment of diffuse alveolar haemorrhage from a range of medical causes, but its efficacy in blast lung is unknown. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Jason E, Watts, S, Spear, A M, Wilson, C, Kirkman, E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581091/
https://www.ncbi.nlm.nih.gov/pubmed/30420554
http://dx.doi.org/10.1136/jramc-2018-001029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581091/
https://www.ncbi.nlm.nih.gov/pubmed/30420554
http://dx.doi.org/10.1136/jramc-2018-001029

Ejemplares similares